Alnylam's gene silencing drug wins FDA approval Ruby Khatun Khatun15 Aug 2018 10:00 AM ISTAlnylam Pharmaceuticals Inc’s drug for a rare hereditary disease won U.S. regulatory approval, becoming the first approved treatment from a new class...
Biogen's pricey muscle drug Spinraza too costly for Britain Ruby Khatun Khatun15 Aug 2018 9:45 AM ISTLONDON: Biogen's muscle disease treatment Spinraza has been deemed too expensive for use on Britain's state-run health service, even after a price...
Bayer shares fall 10 pct after Monsanto's Roundup cancer trial Ruby Khatun Khatun15 Aug 2018 9:30 AM ISTFRANKFURT: Bayer shares plunged more than 10 percent after a California jury ordered the German company's newly acquired Monsanto subsidiary to pay...
Telangana attracts over Rs 10,000 crore in Life Sciences in 4 years Ruby Khatun Khatun14 Aug 2018 11:00 AM ISTHyderabad: Telangana, already home to pharma majors such as Aurobindo Pharma and Dr Reddy's, attracted over Rs 10,000 crore investments in the life...
Pharma exports to cross USD 19 billion in FY19: Pharmexcil Ruby Khatun Khatun14 Aug 2018 10:30 AM ISTNew Delhi: Pharmaceutical exports from the country are expected to cross USD 19 billion in worth during the current fiscal despite muted growth in the...
Apollo Munich Health Insurance strengthens its foothold in West Bengal Ruby Khatun Khatun14 Aug 2018 10:15 AM ISTDurgapur: Apollo Munich Health Insurance announced its plans to strengthen its foothold in West Bengal with the opening of its branch office in...
Insys to pay 150 million dollar to settle US opioid kickback probe Ruby Khatun Khatun14 Aug 2018 10:00 AM ISTInsys Therapeutics said it had reached a deal to pay at least $150 million to resolve a U.S. Justice Department investigation into claims that the...
USFDA panel backs approval of Paratek's antibiotic for pneumonia Ruby Khatun Khatun14 Aug 2018 9:45 AM ISTA U.S. Food and Drug Administration (USFDA) expert panel voted in favor of approval of Paratek Pharmaceuticals Inc’s antibiotic to treat bacterial...
EU says second China company made tainted heart drug Ruby Khatun Khatun14 Aug 2018 9:30 AM ISTFRANKFURT: The European Medicines Agency (EMA) said that a second Chinese contract manufacturer, Zhejiang Tianyu, had produced a common blood pressure...
Glenmark Q1 net profit at Rs 232.99 crore Ruby Khatun Khatun13 Aug 2018 11:00 AM ISTNew Delhi: Pharma major Glenmark Pharmaceuticals reported a consolidated net profit of Rs 232.99 crore in the first quarter ended June 30, 2018.The...
Religare Enterprises to classify promoters as public shareholders Ruby Khatun Khatun13 Aug 2018 10:45 AM ISTNew Delhi: Financial services conglomerate Religare Enterprise said the promoter and promoter groups of the company will be reclassified into a public...
Hetero pulls heart drug from US amid cancer risk probes Ruby Khatun Khatun13 Aug 2018 10:30 AM ISTMUMBAI: A unit of Hetero Drugs is recalling some batches of the blood pressure and heart medicine valsartan in the United States, a notice on the U.S....
